CTRI/2022/07/044204招募中3 期
Effect of Guduchyadi tablet (Tinospora based herbal formulation) in the management of newly diagnosed mild COVID-19 patients, to reduce the risk of hospitalization or death: A randomized double-blind placebo-controlled trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subject aged 18 to 70 years (both inclusive) of both gender
- •Subject with SARS-CoV-2 infection confirmed through reverse transcription followed by polymerase chain reaction (RT- PCR)
- •RT PCR negative COVID 19 suspected symptomatic subject defined as having strong suspicion of atleast 3 or more symptoms as per WHO or ICMR compatible with covid 19 and or having exposure to Covid 19 cases
- •Subject with mild manifestations of COVID-19 (ICMR guidelines, 2022)
- •Subject with initial onset of signs/symptoms attributable to COVID-19 for <=5 days prior to the day of randomization
- •Subject with ability to swallow and retain oral medication
- •Subject with willingness and ability to comply with trial and follow-up procedures.
- •Subject with ability to understand the nature of this trial and give written informed consent
排除标准
- •Subject with RT-PCR positive COVID-19 with no symptoms
- •Subject who is currently hospitalized or is expected to need hospitalization for COVID-19 within 48 hours of randomization.
- •Subject with moderate, severe and critical COVID-19 (ICMR guidelines, 2022)
- •Subject in which the present episode of infection is a recurrence or reinfection of COVID-19 (within 90 days)
- •Subject with underlying non-Communicable diseases like cardiovascular disease, hypertension, and CAD, DM (Diabetes Mellitus) and other immunocompromised states, active tuberculosis, chronic lung/kidney/liver disease, cerebrovascular diseases and obesity
- •Subject with aspartate aminotransferase (AST)/alanine transaminase (ALT) more than 3 times the upper limit of normal reference range
- •Subject who is pregnant, lactating or planning pregnancy during the study period
- •Subject on steroid or other immunosuppressive medication
- •Subject with a history of receiving any allopathic or alternative (herbal) medication, any antiviral drugs with reported activity against COVID-19 (ivermectin, favipiravir, hydroxychloroquine, lopinavir, and remdesivir) or warfarin therapy for the present COVID-19 episode within 7 days before enrolment
- •Subject with unstable or life-threatening systemic diseases like immunodeficiency virus (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV) with cirrhosis, end-stage liver disease, carcinoma, respiratory failure and end stage renal disease
- •Subject with a platelet count <100,000/μL or who have received a platelet transfusion in the 5 days prior to randomization
- •Subject having hypersensitivity or other contraindication to any of the components of the study interventions as determined by the principal investigator
- •Subject with conditions that could limit gastrointestinal absorption of tablet contents
- •Subject who is already participating in another trial or have received an experimental drug or have used an experimental medical device within 30 days prior to the planned start of procedure
- •Subject unlikely to comply with the procedure or complete the scheduled follow up visit, in the opinion of principal investigator
- •Employee of the principal investigator or study center with direct involvement in the proposed study or other studies under the direction of that principal investigator or study center
- •Other indication-based exclusion, in opinion of principal investigator
研究者
相似试验
尚未招募
2 期
Effect Ayurvedic Herb Gulvel/ Guduchi in oral cancer, white patch.CTRI/2024/07/071240Shakyatantra Department of Tilak Ayurved Mahavidyalaya
尚未招募
2 期
Antiobesity effect of Ayurvedic medicinal plants(Giloy & Nagarmotha)CTRI/2018/08/015160ational institute of ayurveda
尚未招募
2 期
Guduchyadi yog in high cholesterolCTRI/2021/03/032077DSRRAU Jodhpur Rajasthan
尚未招募
不适用
Ayurvedic management for skin diseaseCTRI/2021/09/036804Dr Akshata Sanjay Chavan
尚未招募
1 期
Treatment For Itching With RednessCTRI/2018/12/016582Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Karwar Nagaur Road Jodhpur